Age‐specific effect of transurethral holmium laser enucleation of the prostate on overactive bladder in men with benign prostatic hyperplasia: An investigation using an overactive bladder symptom score. Issue 2 (11th December 2022)

• Record Type: Journal Article
• Authors: Takeuchi, Yasuharu; Sawada, Yoshitomo; Watanabe, Shoutarou; Ni‐itsu, Yasuo; Sekido, Noritoshi
• Is Part Of: LUTS. Volume 15:Issue 2(2023)
• Page Start: 38
• Page End: 49
• Publication Date: 2022-12-11
• Subjects: benign prostatic hyperplasia -- laser surgery -- overactive bladder -- prostatectomy -- transurethral -- questionnaire; Urology -- Periodicals; Urologic Diseases -- Periodicals; Urinary Tract Physiological Phenomena -- Periodicals; 616.62
• DOI: 10.1111/luts.12469
• Languages: English
• ISSNs: 1757-5664

Abstract

Abstract: Objectives: To investigate the age‐specific effect of transurethral holmium laser enucleation of the prostate (HoLEP) on overactive bladder (OAB). Methods: A total of 186 consecutive patients who underwent HoLEP were included. They were divided into three groups: patients aged less than 65 years, between 65 and 74, and 75 or older. The OAB symptom score as well as other relevant variables of lower urinary tract symptoms and function were assessed before and 1, 3, 6, and 12 months after surgery. Age‐specific prevalence of OAB, the proportion of resolution of OAB, and de novo OAB were evaluated. Results: The mean age of patients was 70.7 years, and the mean total prostate volume was 75.8 ml. The mean OAB symptom scores before surgery of patients aged less than 65 years, between 65 and 74, and 75 or older were 6.0, 5.2, and 5.7, respectively. At 12 months after surgery, the scores for the respective groups had significantly decreased to 2.1, 2.5, and 3.5. The prevalence of OAB based on the score in the respective groups was 45.8%, 56.9%, and 54.0% ( p = .6391) preoperatively and 9.1%, 11.3%, and 15.8% at 12 months after the surgery ( p = .7613). Of those with preoperative OAB, 75.0%, 79.2%, and 75.0% of the respective groups showed resolution of OAB at 12 months postoperatively ( p = .9427). Conclusions: In candidates for surgical deobstruction of benign prostatic hyperplasia, HoLEP has potential to improve OAB symptoms regardless of age.